The
Renaissance
Series
Striving for TRANSFORMATIONAL VALUE:
Are we ready for radical change?
NOW AVAILABLE: White Paper Tranformational Value | Preparing for a decade of radical change
NEXT EVENT: PARIS, Date and format TBA
Goal & Purpose
White Paper
Next Event
What is the Renaissance Series?
Goal & Purpose
We have reached an inflexion point, where the extraordinary advances in science-led pioneering treatments and the capabilities of digital technologies are promising to radically transform healthcare.
“How do we translate this ground-breaking innovation into life-changing and life-time affordable value for patients, healthcare professionals and society?”
These are disruptive times for healthcare, and the pharmaceutical industry has an opportunity, and an obligation, to ‘think bigger’ about the opportunities to provide Transformational Value.
“What steps must we as an industry take to achieve the desired transformation in healthcare?”
White Paper
Transformational value:
Preparing for a decade of radical change
Synopsis: Transformational Value refers to the pioneering treatments that herald a period of radical change in healthcare and the need to translate these into affordable therapeutic solutions for patients and society.
Our Renaissance faculty examines the dynamic drivers for lifechanging healthcare solutions, and the opportunity for companies to take a big picture view of ‘Transformational Value’ in order to play a meaningful role.
PARIS FORUM
- A unique opportunity to spend a day in closed meeting discussion of the most disruptive driver of change in healthcare today.
- Hear the views of expert speakers from a physician, payer, patient and pharma perspective, all actively involved in addressing the transformation facing healthcare.
- Reflect on your own company strategy through informed discussion with the faculty and like-minded senior influencers from leading pharma companies.
Expert Faculty
Stuart Cooper
CEO Adelphi, Meeting Chair
Indranil Bagchi
SVP Global Value and Access, Novartis (Kymriah, CAR-T)
Mads Lennox Hvenekilde
Lifecycle leader, Global Product Strategy, F. Hoffmann-La Roche
John New
COO NorthWest E-Health; Physician and Professor Salford Royal Foundation Trust
Inka Heikkinen
Formerly Head of Scientific Programmes, EMEA at DIA
What is the Renaissance Series?
Expert exchange on disruptive drivers in healthcare
Adelphi’s Renaissance events have, over the years, become established as unique, one day invitation-only forums, at which senior Pharma leaders have the opportunity for discussion of the most dynamic drivers of major and disruptive change in Pharma in an intimate setting.
One Day Thought Leadership Forums based on issues that are driving major change in our industry, most recent forums have addressed:
- Striving for Transformational Value 2018-2020
- Patientcentricity: Defining our role 2016-2017
- Real World Evidence: the new standard of proof? 2014-2015
- Personalised Medicine: Moving from promise to practice 2012-2013
Each Adelphi Renaissance forum has its own unique expert faculty, who are passionate about the topic, representing a range of perspectives from academia, the medical profession, pharma industry, patients, regulatory and payer bodies.
The
Renaissance
Series
Striving for TRANSFORMATIONAL VALUE:
Are we ready for radical change?
NOW AVAILABLE: White Paper Transformational Value|Preparing for a decade of radical change
NEXT EVENT: PARIS, Date and format TBA
GOAL & PURPOSE
WHY ATTEND?
REGISTER TO ATTEND
PROGRAMME
WHAT IS THE RENAISSANCE SERIES?
Goal & Purpose
We have reached an inflexion point, where the extraordinary advances in science-led pioneering treatments and the capabilities of digital technologies are promising to radically transform healthcare.
These are disruptive times for healthcare and the pharmaceutical industry has an opportunity, and an obligation, to ‘think bigger’ about the opportunities to provide Transformational Value.
“How do we translate this ground-breaking innovation into life-changing and life-time affordable value for patients, healthcare professionals and society?”
“What steps must we as an industry take to achieve the desired transformation in healthcare?”
WHITE PAPER
Transformational value:
Preparing for a decade of radical change
Synopsis: Transformational Value refers to the pioneering treatments that herald a period of radical change in healthcare and the need to translate these into affordable therapeutic solutions for patients and society.
Our Renaissance faculty examines the dynamic drivers for lifechanging healthcare solutions, and the opportunity for companies to take a big picture view of ‘Transformational Value’ in order to play a meaningful role.
Why Attend?
- A unique opportunity to spend a day in closed meeting discussion of the most disruptive driver of change in healthcare today.
- Hear the views of expert speakers from a physician, payer, patient and pharma perspective, all actively involved in addressing the transformation facing healthcare.
- Reflect on your own company strategy through informed discussion with the faculty and like-minded senior influencers from leading pharma companies.
Expert Faculty
Stuart Cooper
CEO Adelphi, Meeting Chair
Indranil Bagchi
SVP Global Value and Access, Novartis (Kymriah, CAR-T)
Mads Lennox Hvenekilde
Lifecycle leader, Global Product Strategy, F. Hoffmann-La Roche
John New
COO NorthWest E-Health; Physician and Professor Salford Royal Foundation Trust
Inka Heikkinen
Formerly Head of Scientific Programmes, EMEA at DIA
Programme Summary
A New Tomorrow: Keynote address
Calculating and demonstrating value of transformative therapies
Frameworks to fit a changing landscape
Digital and AI: Creating and measuring holistic value to patients and society
Agility: Leading the way with pioneering organisational transformation
Pivotal role for Medical Affairs
What is the Renaissance Series?
Expert exchange on disruptive drivers in healthcare
Adelphi’s Renaissance events have, over the years, become established as unique, one day invitation-only forums, at which senior Pharma leaders have the opportunity for discussion of the most dynamic drivers of major and disruptive change in Pharma in an intimate setting.
One Day Thought Leadership Forums based on issues that are driving major change in our industry, most recent forums have addressed:
- Striving for Transformational Value 2018-2019
- Patientcentricity: Defining our role 2016-2017
- Real World Evidence: the new standard of proof? 2014-2015
- Personalised Medicine: Moving from promise to practice 2012-2013
Each Adelphi Renaissance forum has its own unique expert faculty, who are passionate about the topic, representing a range of perspectives from academia, the medical profession, pharma industry, patients, regulatory and payer bodies.
